- Home
- APA vs BRKR Comparison
APA vs BRKR Comparison
Compare APA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APA
- BRKR
- Stock Information
- Founded
- APA 1954
- BRKR 1991
- Country
- APA United States
- BRKR United States
- Employees
- APA N/A
- BRKR N/A
- Industry
- APA Oil & Gas Production
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- APA Energy
- BRKR Industrials
- Exchange
- APA Nasdaq
- BRKR Nasdaq
- Market Cap
- APA 8.3B
- BRKR 9.1B
- IPO Year
- APA N/A
- BRKR 2000
- Fundamental
- Price
- APA $21.04
- BRKR $57.00
- Analyst Decision
- APA Hold
- BRKR Buy
- Analyst Count
- APA 20
- BRKR 13
- Target Price
- APA $30.79
- BRKR $75.67
- AVG Volume (30 Days)
- APA 7.1M
- BRKR 1.5M
- Earning Date
- APA 02-19-2025
- BRKR 02-11-2025
- Dividend Yield
- APA 4.75%
- BRKR 0.35%
- EPS Growth
- APA 34.29
- BRKR N/A
- EPS
- APA 6.58
- BRKR 2.06
- Revenue
- APA $8,955,000,000.00
- BRKR $3,241,300,000.00
- Revenue This Year
- APA $12.54
- BRKR $15.26
- Revenue Next Year
- APA N/A
- BRKR $7.64
- P/E Ratio
- APA $3.20
- BRKR $27.65
- Revenue Growth
- APA 6.11
- BRKR 15.00
- 52 Week Low
- APA $20.32
- BRKR $48.07
- 52 Week High
- APA $37.82
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- APA 39.03
- BRKR 47.72
- Support Level
- APA $20.32
- BRKR $54.62
- Resistance Level
- APA $23.10
- BRKR $58.32
- Average True Range (ATR)
- APA 0.79
- BRKR 2.30
- MACD
- APA -0.10
- BRKR -0.22
- Stochastic Oscillator
- APA 25.90
- BRKR 32.65
About APA APA Corporation
Based in Houston, APA is an independent exploration and production company. It operates primarily in the US, Egypt, the North Sea, and Suriname. At year-end 2023, proved reserves totaled 807 million barrels of oil equivalent, with net reported production of 405 thousand boe/day that year (64% of which was oil and natural gas liquids, with the remainder natural gas).
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.